- Home
- SRPT vs GRDN Comparison
SRPT vs GRDN Comparison
Compare SRPT & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- GRDN
- Stock Information
- Founded
- SRPT 1980
- GRDN 2004
- Country
- SRPT United States
- GRDN United States
- Employees
- SRPT N/A
- GRDN N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- GRDN Retail-Drug Stores and Proprietary Stores
- Sector
- SRPT Health Care
- GRDN Consumer Staples
- Exchange
- SRPT Nasdaq
- GRDN Nasdaq
- Market Cap
- SRPT 1.9B
- GRDN 1.7B
- IPO Year
- SRPT 1997
- GRDN 2024
- Fundamental
- Price
- SRPT $17.65
- GRDN $28.68
- Analyst Decision
- SRPT Hold
- GRDN Strong Buy
- Analyst Count
- SRPT 30
- GRDN 2
- Target Price
- SRPT $35.93
- GRDN $30.00
- AVG Volume (30 Days)
- SRPT 6.1M
- GRDN 298.0K
- Earning Date
- SRPT 11-03-2025
- GRDN 11-10-2025
- Dividend Yield
- SRPT N/A
- GRDN N/A
- EPS Growth
- SRPT N/A
- GRDN N/A
- EPS
- SRPT N/A
- GRDN N/A
- Revenue
- SRPT $2,413,715,000.00
- GRDN $1,326,604,000.00
- Revenue This Year
- SRPT $10.20
- GRDN $16.33
- Revenue Next Year
- SRPT N/A
- GRDN $2.10
- P/E Ratio
- SRPT N/A
- GRDN N/A
- Revenue Growth
- SRPT 47.15
- GRDN 18.53
- 52 Week Low
- SRPT $10.42
- GRDN $17.78
- 52 Week High
- SRPT $138.81
- GRDN $30.39
- Technical
- Relative Strength Index (RSI)
- SRPT 38.30
- GRDN 64.59
- Support Level
- SRPT $15.08
- GRDN $27.90
- Resistance Level
- SRPT $18.80
- GRDN $29.39
- Average True Range (ATR)
- SRPT 1.40
- GRDN 1.16
- MACD
- SRPT -0.84
- GRDN 0.08
- Stochastic Oscillator
- SRPT 24.92
- GRDN 82.02
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.